← All stocks

Phathom Pharmaceuticals, Inc.

PHAT Net selling
CIK 0001783183 #2855 in the set updated 19 Sep 2026
Bought (12 mo)
$0.00
out of their own pocket, the only kind of buying there is
Sold (12 mo)
$7.08K
$0.00 on a plan · $0.00 straight out of an exercise
Sold at will
$7.08K
1 of 1 sales
Net
−$7.08K
−$7.08K against sales at will

By person

14 insiders · 4 transactions
Insider
Role
Bought
Sold
Net
Holding
Of company
Worth
Change
Breedlove Robert Charles
Principal Accounting Officer
$7.08K (1)
−$7.08K
67,657
0.0836%
$914.04K
+14.8%
Basta Steven L
President and CEO
373,315
0.4614%
$5.04M
+15,390%
Curran Terrie
President and Chief Executive
360,465
0.4456%
$4.87M
−5.0%
Nabulsi Azmi
Chief Operating Officer
312,590
0.3864%
$4.22M
+29.0%
Narula Sanjeev
Chief Financial & Bus. Officer
226,715
0.2802%
$3.06M
+57.4%
Parikh Asit
Director
172,622
0.2134%
$2.33M
+136.5%
Topper James N
Director
126,121
0.1559%
$1.70M
+292.9%
KARBE FRANK
Director
91,622
0.1133%
$1.24M
+105.9%
Henderson Molly
CFO and CBO
89,868
0.1111%
$1.21M
+205.5%
Cook Anne Marie
Chief Legal Off. & Corp. Sec.
88,660
0.1096%
$1.20M
+5,049%
COLA MICHAEL F
Director
63,920
0.0790%
$863.56K
+118.2%
FIELDS HEIDI
Director
54,122
0.0669%
$731.19K
+177.5%
Stenhouse Mark
Director
54,122
0.0669%
$731.19K
+177.5%
Schroeder Theodore R
Director
45,122
0.0558%
$609.60K
Insider
Date
Role
Action
Shares
Price
Amount
Parikh Asit
20 May 2026
Director
Exercised, kept
17,500
$4.95
$86.63K
Parikh Asit
13 Jan 2026
Director
Exercised, kept
8,750
$10.30
$90.13K
Parikh Asit
19 Dec 2025
Director
Exercised, kept
8,750
$10.30
$90.13K

What was left out

Form 4 filings counted 28
Amendments (4/A) skipped 1
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 0
Sales at will 1
Transactions with no price 0
Shares from compensation/vesting 1,349,135
History held since 30 Oct 2019